Dear Doctor Letter (Rote-Hand-Brief) on contrast media containing gadolinium: updated recommendations for use
2018.01.10
Active substance: gadolinium
The marketing authorisation holders concerned are circulating information on indications confirmed by the European Medicines Agency (EMA) regarding low levels of gadolinium deposition in the brain following administration of contrast media containing gadolinium.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN